Abstract
Why are some less solidly supported health care innovations widely adopted while others with apparently stronger scientific support remain underused? Drawing on four case studies, the authors argue that the way in which the distribution of benefits and risks map onto the interests, values, and power distribution of the adopting system is critical to understanding how innovations diffuse.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cholecystectomy, Laparoscopic
-
Decision Making*
-
Diffusion of Innovation*
-
Evidence-Based Medicine*
-
Filtration / instrumentation
-
Health Services Research
-
Heparin, Low-Molecular-Weight / therapeutic use
-
Humans
-
Organizational Case Studies
-
Organizational Innovation
-
Power, Psychological
-
Process Assessment, Health Care
-
Renal Dialysis / instrumentation
-
Risk Assessment
-
Therapeutic Community
-
Venous Thrombosis / drug therapy
Substances
-
Heparin, Low-Molecular-Weight